Pediatric Retinal Disorders: A Parent’s Guide
Understanding Pediatric Retinal Conditions
The retina is a thin layer of tissue that lines the back of the eye. It contains millions of light-sensitive cells that convert light into electrical signals. These signals travel through the optic nerve to the brain, where they are processed into the images we see. When the retina does not develop properly or becomes damaged, vision can be seriously affected.
Retinal disorders in children differ from those in adults in several important ways. A child's visual system is still developing, so early detection and treatment can have a major impact on lifelong vision. Children may not be able to describe what they see or recognize that their vision is abnormal. This makes regular eye exams and screening especially important during infancy and childhood.
Pediatric retinal conditions generally fall into a few categories. Some are caused by premature birth, such as retinopathy of prematurity. Others are inherited genetic conditions, including Stargardt disease, Best disease, juvenile retinoschisis, and familial exudative vitreoretinopathy. Retinal detachments can also occur in children, often due to trauma or high myopia (nearsightedness). Each condition requires a different approach to diagnosis and management.
Who Is Affected and Risk Factors
Babies born before 31 weeks of gestation or weighing less than 1,500 grams (about 3.3 pounds) at birth face the highest risk for retinopathy of prematurity (ROP). About half of the estimated 28,000 premature babies born each year in the United States have some degree of ROP (Children's Hospital Boston). The prevalence of ROP ranges from 5 to 8 percent in developed countries with adequate neonatal care to up to 30 percent in middle-income developing countries (published prevalence data).
Additional risk factors for ROP include breathing problems, excessive oxygen therapy, infections, and other medical complications common in premature infants. Poor weight gain after birth is also associated with a higher risk.
Several retinal disorders run in families due to specific gene mutations. Stargardt disease is the most common inherited macular dystrophy (a condition that damages the central part of the retina), affecting an estimated 1 in 8,000 to 1 in 10,000 people. It is caused by mutations in the ABCA4 gene (published genetic data). Best disease, also called Best vitelliform macular dystrophy (BVMD), affects approximately 1 in 16,500 to 1 in 21,000 individuals in the United States (Olmsted County population study). Juvenile retinoschisis is an X-linked disorder, meaning the genetic mutation is found on the X chromosome. It overwhelmingly affects males, who inherit the affected chromosome from their mothers.
Retinal detachments in children are uncommon but serious. Of all retinal detachments identified in one large study, only 1.3 percent occurred in patients aged 1 to 17 years (PubMed, 2023). The most common cause of retinal detachment in children is trauma, accounting for about 44 percent of pediatric cases, followed by myopia at 15 percent and complications from previous eye conditions (published clinical data). Trauma is a major risk factor regardless of geography, especially in young males. In East Asia, where rates of myopia are higher, more pediatric retinal detachments are related to myopic changes in the eye.
Signs and Symptoms
ROP does not cause visible signs that parents can see on their own. In advanced cases, the retina may partially or completely pull away from the back of the eye, a condition called retinal detachment. This can cause significant vision loss or blindness. If a baby had ROP that caused damage, parents may later notice that the child's eyes wander, shake, or make other unusual movements. Because there are no early outward signs, routine screening by a trained eye specialist is essential for all at-risk infants.
Children with inherited retinal conditions such as Stargardt disease may first notice difficulty reading, problems with central vision, or trouble seeing in dim light. Visual acuity often declines during childhood and adolescence, then tends to stabilize in adulthood before declining again later in life (published clinical observations). In conditions like juvenile retinoschisis, severe complications can develop, including splitting of the retinal layers, retinal detachment, or vitreous hemorrhage (bleeding inside the eye). These complications can further impair vision or lead to blindness.
Because many retinal conditions develop without obvious symptoms, parents should be aware of signs that may suggest a vision problem. These include:
- Difficulty tracking objects or making eye contact in infants
- Eyes that wander, cross, or shake
- Holding books or screens very close to the face
- Squinting, tilting the head, or covering one eye
- Complaints of blurry or distorted vision in older children
- Difficulty seeing at night or in low light
Certain symptoms in children require immediate medical evaluation. If a child reports a sudden increase in floaters (spots or lines drifting across their vision), flashes of light, a shadow or curtain across their field of vision, or sudden loss of vision in one eye, see a retina specialist or go to the emergency room immediately. These may be signs of a retinal detachment or other serious condition that can cause permanent vision loss if not treated quickly.
Diagnosis and Testing
All premature infants who meet certain criteria based on birth weight and gestational age should be screened for ROP. This screening is typically performed in the neonatal intensive care unit (NICU) by an ophthalmologist who specializes in retinal conditions. The examination involves dilating the baby's pupils and using a special instrument to view the retina. The timing of the first exam and follow-up schedule depend on how early the baby was born.
Diagnosing retinal disorders in children requires a full ophthalmologic examination with the pupils dilated so the retina specialist can see the back of the eye clearly. For inherited conditions, the doctor may use imaging tools such as optical coherence tomography (OCT), which creates detailed cross-section images of the retina, and fundus photography, which takes pictures of the retinal surface. Electroretinography (ERG), a test that measures the electrical response of the retina to light, can also help identify specific types of retinal dysfunction.
For suspected inherited retinal conditions, genetic testing plays an increasingly important role. Identifying the specific gene mutation responsible for a condition helps confirm the diagnosis, predict how the condition may progress, and determine whether other family members may be at risk. Genetic testing is especially relevant for conditions like Stargardt disease, Best disease, juvenile retinoschisis, and familial exudative vitreoretinopathy (FEVR). Knowing the exact genetic cause also helps determine whether a child may be eligible for current or future gene therapy clinical trials.
Treatment Options
Laser photocoagulation (a procedure that uses thermal laser energy to treat the retina) has traditionally been the standard treatment for ROP that reaches a stage requiring intervention. The laser is applied to the areas of the retina where blood vessels have not yet developed, which helps prevent the growth of abnormal blood vessels. This treatment has a well-established track record and remains an important option for many infants with ROP.
Intravitreal injections (injections of medication directly into the eye) of anti-VEGF agents have become increasingly common for treating ROP, especially for disease in the most posterior (central) part of the retina. Vascular endothelial growth factor (VEGF) is a protein that drives abnormal blood vessel growth. By blocking VEGF, these medications can halt the progression of ROP.
Avastin (bevacizumab), which is FDA-approved for cancer treatment and used off-label for eye conditions, was one of the first anti-VEGF agents studied for ROP. In a 2011 clinical trial comparing Avastin with conventional laser therapy, Avastin showed a significant benefit for zone I ROP but not for zone II disease (BEAT-ROP trial). Lucentis (ranibizumab) has also gained use for ROP. The long-term safety of anti-VEGF medications in infants has not been fully determined, so retina specialists weigh the benefits and risks carefully for each case.
When a child develops a retinal detachment, surgical intervention is typically required. Options include vitrectomy (a surgery to remove the gel inside the eye and repair the retina), scleral buckle (a silicone band placed around the eye to support the retina), or a combination of both. The choice of procedure depends on the cause and severity of the detachment. Pediatric retinal detachments can be more complex than those in adults, and outcomes depend on how quickly treatment is provided.
There is currently no cure for most inherited retinal dystrophies, including Stargardt disease and juvenile retinoschisis. However, management can make a meaningful difference in a child's quality of life. Children with these conditions can benefit from corrective lenses, low vision aids such as magnifiers and specialized electronic devices, and accommodations at school. Regular follow-up with a retina specialist allows for monitoring of disease progression and early treatment of complications like retinal detachment or vitreous hemorrhage.
Gene therapy is an area of active research that holds significant promise for inherited retinal conditions. Luxturna (voretigene neparvovec) is the first FDA-approved gene therapy for a retinal disease and is used for a specific inherited condition caused by mutations in the RPE65 gene. Multiple gene therapy clinical trials are underway for Stargardt disease and other inherited retinal dystrophies. These treatments aim to correct the abnormal gene in the retina, potentially slowing disease progression and preventing further vision loss. Advances in diagnostic and genetic testing are helping researchers identify which patients may benefit most from these emerging therapies.
What to Expect
If your baby is at risk for ROP, the first screening exam usually takes place in the NICU, typically four to six weeks after birth. If ROP is found, your baby will need follow-up exams on a schedule determined by the retina specialist. Many cases of ROP are mild and resolve on their own without treatment. More severe cases may require laser treatment or anti-VEGF injections within days of diagnosis. After treatment, ongoing monitoring is important to check for complications or recurrence.
Receiving a diagnosis of an inherited retinal condition in your child can be overwhelming. Understanding that most of these conditions progress slowly can provide some reassurance. A retina specialist will develop a long-term monitoring plan tailored to your child's specific condition. Genetic counseling can help families understand the inheritance pattern, the likelihood that other family members may be affected, and what the diagnosis may mean for future generations.
Children with vision loss from retinal conditions can benefit greatly from early intervention and vision rehabilitation services. These may include working with a low vision specialist, using assistive technology in the classroom, and learning strategies to maximize remaining vision. Starting these services early in a child's development can support academic achievement, social development, and independence.
Living with Pediatric Retinal Conditions
A child with a retinal disorder can still thrive with proper support. Early identification of vision problems allows families to put resources in place before the child falls behind. Schools often have services for students with visual impairments, including large print materials, preferential seating, and access to assistive technology. Open communication with teachers, counselors, and the child's healthcare team helps ensure that needs are met.
While genetic conditions cannot be prevented, some causes of pediatric retinal problems can be minimized. Eye protection during sports and other activities reduces the risk of trauma-related retinal detachment, which is the leading cause of retinal detachment in children. Regular comprehensive eye exams can identify conditions like high myopia early, allowing for monitoring and timely intervention if problems develop.
Most pediatric retinal conditions require ongoing monitoring, sometimes for a lifetime. Even after successful treatment for ROP, children remain at higher risk for other eye problems, including myopia, strabismus (misaligned eyes), and amblyopia (reduced vision in one eye). Children with inherited retinal conditions need periodic exams to track changes in their vision and retinal structure. Keeping all scheduled appointments with a retina specialist gives your child the best chance of preserving as much vision as possible.
When to See a Retina Specialist
All babies born before 31 weeks of gestation or weighing less than 1,500 grams at birth should be screened for ROP according to established medical guidelines. Your baby's neonatologist or pediatrician will arrange this screening. If your premature baby has already been discharged from the hospital, confirm that any recommended follow-up eye exams are scheduled.
If your child shows signs of vision difficulty, such as trouble reading, unusual eye movements, or complaints about blurry or distorted vision, an evaluation by an eye care professional is important. An optometrist or pediatric ophthalmologist can perform an initial examination and refer your child to a retina specialist if a retinal condition is suspected.
If there is a known family history of inherited retinal conditions such as Stargardt disease, Best disease, juvenile retinoschisis, or FEVR, early evaluation by a retina specialist is recommended even if your child does not yet show symptoms. Early genetic testing and baseline retinal imaging can guide monitoring and prepare the family for any future changes.
Questions and Answers
Many mild cases of ROP do resolve on their own as the retinal blood vessels complete their development. However, moderate to severe ROP may require treatment to prevent retinal detachment and vision loss. Even children whose ROP resolves without treatment should continue to have regular eye exams, as they remain at higher risk for other vision problems such as myopia and amblyopia later in childhood.
Luxturna (voretigene neparvovec) is currently the only FDA-approved gene therapy for an inherited retinal disease, and it treats a specific condition caused by RPE65 gene mutations. For other conditions like Stargardt disease and juvenile retinoschisis, gene therapy is being studied in clinical trials but is not yet widely available as a standard treatment. Genetic testing can help determine whether a child may be eligible for a current or upcoming clinical trial.
The recommended frequency of eye exams depends on the specific condition and how it is progressing. In general, children with inherited retinal dystrophies should see a retina specialist at least once or twice a year. The specialist may recommend more frequent visits if the condition is changing or if the child is at risk for complications like retinal detachment. Your child's retina specialist will create a personalized monitoring schedule.
Anti-VEGF injections have shown effectiveness in promoting regression of abnormal blood vessel growth in infants with severe ROP. However, the long-term safety profile of these medications in infants has not been fully established. Because VEGF plays a role in the normal development of many organ systems, retina specialists carefully evaluate each case to determine whether the benefits of injection outweigh the potential risks. Ongoing research continues to improve understanding of how these treatments affect developing infants over time.
The most important steps are to follow through with all recommended evaluations and treatments, and to establish a relationship with a retina specialist experienced in pediatric conditions. Pursuing genetic testing when recommended can provide valuable information about the diagnosis and future outlook. Connecting with vision rehabilitation services, school support programs, and family support organizations can help your child adapt and succeed. Staying informed about emerging treatments, including gene therapy research, allows families to take advantage of new options as they become available.